CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Atropine for the prevention of cardiac dysrhythmias in patients with hepatocellular carcinoma undergoing percutaneous ethanol instillation: A, randomized, placebo-controlled, double-blind trial
DOI 10.1055/s-2007-985471
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Ferlitsch, M Schmid, H Schmidinger, M Homoncik, J Pleiner-Duxneuner, G Ulbrich, A Gangl, M Peck-Radosavljevic
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe07/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Percutaneous ethanol injection (PEI) is an established method in the treatment of hepatocellular carcinoma (HCC) and other tumors. During this procedure severe complications including cardiac bradyarrhythmias can occur. Preemptive injection of atropine is recommended by professional guidelines to prevent these dysrhythmias. The usefulness of this application has not been proven. Aim of the study was to…
Zitieren
Zitierempfehlung
A Ferlitsch, M Schmid, H Schmidinger, M Homoncik, J Pleiner-Duxneuner, G Ulbrich, A Gangl, M Peck-Radosavljevic (2007) Atropine for the prevention of cardiac dysrhythmias in patients with hepatocellular carcinoma undergoing percutaneous ethanol instillation: A, randomized, placebo-controlled, double-blind trial. Zeitschrift für Gastroenterologie (07). https://doi.org/10.1055/s-2007-985471
Mit CareLit weiterarbeiten